Powles Highlights “Transformative” Benefit of EV Plus Pembro While Sharing Long-Term Data for EV-302
The lead investigator for EV-302 said not long ago, survival of 12 to 14 months in this type of bladder cancer was considered ...
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback